Serological abnormalities in bird fancier's lung: Author's reply

由 Udwadia, Zarir F
出版 1990

Disseminated tuberculosis with immune thrombocytopenic purpura

由 Dagaonkar, Rucha S., Udwadia, Zarir F.
出版 2012

Multidrug-resistant-tuberculosis treatment in the Indian private sector: Results from a tertiary referral private hospital in Mumbai

由 Udwadia, Zarir F., Moharil, Gautam
發表在 Lung India (2014)

Private patient perceptions about a public programme; what do private Indian tuberculosis patients really feel about directly observed treatment?

由 Pinto, Lancelot M, Udwadia, Zarir F
出版 2010

How to protect the protectors: 10 lessons to learn for doctors fighting the COVID-19 coronavirus

由 Udwadia, Zarir F., Raju, Reyma Sara
發表在 Med J Armed Forces India (2020)

The N-95 mask: Invaluable ally in the battle against the COVID-19 pandemic

由 Udwadia, Zarir F., Raju, Reyma Sara
發表在 Lung India (2020)

Oxaliplatin-induced lung fibrosis

由 Shah, Arpan, Udwadia, Zarir F., Almel, Sachin
出版 2009

Favipiravir: A new and emerging antiviral option in COVID-19

由 Agrawal, Umang, Raju, Reyma, Udwadia, Zarir F.
發表在 Med J Armed Forces India (2020)

Post-COVID lung fibrosis: The tsunami that will follow the earthquake

由 Udwadia, Zarir F, Koul, Parvaiz A, Richeldi, Luca
發表在 Lung India (2021)

Tuberculosis Management by Private Practitioners in Mumbai, India: Has Anything Changed in Two Decades?

由 Udwadia, Zarir F., Pinto, Lancelot M., Uplekar, Mukund W.
出版 2010

Tropical pulmonary eosinophilia - A review

由 Mullerpattan, Jai B., Udwadia, Zarir F., Udwadia, Farokh E.
出版 2013

Neuropsychiatric reactions induced by cycloserine in the treatment of multidrug-resistant tuberculosis: what an Indian female patient tells us

由 Intini, Enrica, Kishore, Girija, Richeldi, Luca, Udwadia, Zarir F
發表在 BMJ Case Rep (2019)

Safety of Rifabutin in patients with rifampicin-induced thrombocytopenia

由 Sarkar, Trina, Riccardi, Niccolò, Wagh, Haresh, Udwadia, Zarir F
發表在 Lung India (2020)

Primary immune deficiency in the intensive care unit: It is never too late to diagnose and treat

由 Dagaonkar, Rucha S., Sen, Tiyas, Udwadia, Zarir F., Desai, Mukesh B.
出版 2011

Improved pulmonary function following pirfenidone treatment in a patient with progressive interstitial lung disease associated with systemic sclerosis

由 Udwadia, Zarir F., Mullerpattan, Jai B., Balakrishnan, Canchi, Richeldi, Luca
發表在 Lung India (2015)

Possible impact of the standardized Category IV regimen on multidrug-resistant tuberculosis patients in Mumbai

由 Udwadia, Zarir F, Mullerpattan, Jai Bharat, Shah, Kushal D, Rodrigues, Camilla S
發表在 Lung India (2016)

Effective use of telemedicine in Mumbai with a cohort of extensively drug-resistant “XDR” tuberculosis patients on bedaquiline during COVID-19 pandemic

由 Udwadia, Zarir F., Sharma, Samridhi, Mullerpattan, Jai B., Gajjar, Ishita, Pinto, Lancelot
發表在 Lung India (2021)

Idiopathic pulmonary fibrosis in BRIC countries: the cases of Brazil, Russia, India, and China

由 Richeldi, Luca, Rubin, Adalberto Sperb, Avdeev, Sergey, Udwadia, Zarir F., Xu, Zuo Jun
發表在 BMC Med (2015)

Few eligible for the newly recommended short course MDR-TB regimen at a large Mumbai private clinic

由 Udwadia, Zarir F., Tornheim, Jeffrey A., Ganatra, Shashank, DeLuca, Andrea, Rodrigues, Camilla S., Gupta, Amita
發表在 BMC Infect Dis (2019)

Use of nintedanib in patients with idiopathic pulmonary fibrosis: Initial Indian experience

由 Mullerpattan, Jai B, Porwal, Sana H, Sarkar, Trina A, Wagh, Haresh D, Udwadia, Zarir F
發表在 Lung India (2019)